Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Oncol. Nov 10, 2012; 3(11): 142-149
Published online Nov 10, 2012. doi: 10.5306/wjco.v3.i11.142
Published online Nov 10, 2012. doi: 10.5306/wjco.v3.i11.142
Dendritic cell vaccination in glioblastoma after fluorescence-guided resection
Ricardo Diez Valle, Sonia Tejada, Department of Neurosurgery, University of Navarra Hospital, 31008 Pamplona, Navarra, Spain
Ascension Lopez-Diaz de Cerio, Susana Inoges, Fernando Pastor, Helena Villanueva, Maurizio Bendandi, Lab of Immunotherapy, CIMA, 31008 Pamplona, Navarra, Spain
Susana Inoges, Maurizio Bendandi, Immunotherapy Program, University of Navarra Hospital, 31008 Pamplona, Navarra, Spain
Jaime Gallego, Department of Neurology, University of Navarra Hospital, 31008 Pamplona, Navarra, Spain
Jaime Espinos, Javier Aristu, Department of Oncology, University of Navarra Hospital, 31008 Pamplona, Navarra, Spain
Miguel Angel Idoate, Department of Pathology, University of Navarra Hospital, 31008 Pamplona, Navarra, Spain
Enrique Andreu, Cell Therapy Area, University of Navarra Hospital, 31008 Pamplona, Navarra, Spain
Author contributions: All authors equally contributed to this work.
Supported by Spanish Health Ministry Grant MCI EC08/00186
Correspondence to: Maurizio Bendandi, MD, PhD, Director, Lab of Immunotherapy, CIMA, Cima Avda. Pio XII 55, 31008 Pamplona, Navarra, Spain. mbendandi@unav.es
Telephone: +34-948-255400 Fax: +34-948-296500
Received: August 22, 2012
Revised: October 22, 2012
Accepted: November 2, 2012
Published online: November 10, 2012
Processing time: 217 Days and 18.5 Hours
Revised: October 22, 2012
Accepted: November 2, 2012
Published online: November 10, 2012
Processing time: 217 Days and 18.5 Hours
Core Tip